Viking Therapeutics, Inc. (VKTX)
34.34
+3.65
(+11.89%)
USD |
NASDAQ |
Jan 14, 16:00
34.59
+0.25
(+0.73%)
After-Hours: 20:00
Viking Therapeutics SG&A Expense (TTM): 52.36M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 10.39B |
| Pfizer Inc. | 13.91B |
| Amgen, Inc. | 6.976B |
| Altimmune, Inc. | 22.68M |
| Moderna, Inc. | 1.061B |